Lille

• Clinical trial of MK-7648A in adults and children with skin cancer Not authorised
  2022-501417-31-00 5 High-risk Resected Melanoma
• Safety, tolerability, and efficacy of mFOLFIRINOX ±BNT321 as adjuvant therapy following curative resection in patients with pancreatic adeno … Not authorised
  2023-506014-47-00 9 Resected (R0 or R1) pancreatic ductal adenocarcinoma
• PROSTABACT : Relevance of the treatment with antibiotics before endoscopic surgery of lower urinary symptoms related to prostate hypertrophy … Not authorised
  2023-510191-31-00 5 Benign Prostate Hyperplasia
• Phase 3 Study of Telitacicept in Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2) Not authorised
  2024-512716-21-00 5 Moderately to Severely Active Systemic Lupus Erythematosus
• PRODIGE 113 (FFCD 2314) – REWENEC – 01 STUDY Randomized trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI with a hybrid synthetic co … Not authorised
  2024-519922-19-00 4 Neuroendocrine carcinoma of gastro-enteropancreatic or unknown origin
• Stroke in childhood due to inflammatory narrowing of blood vessels: Treatment with steroids Pending
  2022-500631-36-00 5 Focal cerebral arteriopathy and childhood stroke Focal cerebral arteri
• Double blind, multicenter, randomized, controlled trial of dexmedetomidine vs placebo in premature neonates receiving invasive ventilation Pending
  2023-509247-27-00 5 Neonatal respiratory distress. Pain and discomfort
• IntReALL BCP 2020 – International Study for Treatment of Childhood Relapsed Precursor B-cell ALL 2020 Pending
  2023-509392-17-00 5 Relapsed Acute Lymphoblastic Leukemia (ALL)
• Efficacy and Safety of Cryotherapy followed by Tirbanibulin ointment for actinic keratosis on the scalp and forehead Pending
  2023-509931-15-00 11 Patients (male or female) ≥18 years old with scalp and forehead actini
• Study of the effect and tolerability of INT230-6 by direct injection into the tumor, followed by neoadjuvant treatment with chemoimmunothera … Pending
  2024-512511-49-00 4 Early triple-negative breast cancer (TNBC)
• SIOP PNET 5 medulloblastoma Pending
  2024-513724-42-00 10 Medulloblastoma
• PRESENT - Prophylaxis of Recurrent Erysipelas in lower limbs: compreSsion thErapy vs aNTibiotics and compression therapy. A non-inferiority, … Pending
  2024-513801-30-00 5 Recurrent Erysipelas in lower limbs
• CAALL-F01: a French protocol for the treatment of acute lymphoblastic leukemia (ALL) in children and adolescents Pending
  2024-514243-29-01 5 This is a prospective, French, multicenter, open-label, design, strati
• Comparison of azathioprine to methotrexate in combination therapy with adalimumab in Crohn’s Disease: an open-label randomized controlled tr … Pending
  2024-514633-38-00 5 Crohn’s Disease
• FirST lines of biologics in pAtients with ulceRaTivE colitis: a Randomised controlled trial Pending
  2024-514964-24-00 5 ulcerative colitis
• Severe Erythema Multiforme - CORTICO Pending
  2024-516018-39-00 5 Erythema multiforme (EM) in its severe form managed at the hospital
• BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma Pending
  2024-516115-24-00 9 High risk relapsed neuroblastoma (relapsed or progressed after being d
• CANDIDATE THERAPIES IN COMBINATION OR SEQUENTIALLY WITH TYROSINE KINASE INHIBITORS IN CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML) P … Pending
  2024-516328-32-00 4 CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML)
• ALADDIN: evaluation of dAroLutamide Addition to anDrogen Deprivation therapy and radIatioN therapy in newly diagnosed prostate cancer with p … Pending
  2024-517285-41-00 5 Newly diagnosed prostate cancer with pelvic lymph nodes metastases
• A multi-part study to investigate MTX325 in healthy volunteers and patients with Parkinson's Disease Pending
  2024-517310-15-00 3 Parkinson's Disease
• A Phase III study evaluating the efficacy of atezoliumab administration in addition to BCG (Bacillus Calmette-Guerin) for 1 year in patient … Pending
  2024-517621-54-00 5 High-risk non-muscle invasive bladder cancer (NMIBC) after transurethr
• Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Duct … Pending
  2024-518139-12-00 4 locally advanced or metastatic Pancreatic ductal adenocarcinoma
• Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma pat … Pending
  2024-518199-30-00 9 Soft tissue sarcoma patients
• A phase 2 study of ianalumab in adults with primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) who … Pending
  2024-518231-11-00 4 Immune thrombocytopenia (ITP) Warm autoimmune hemolytic anemia (wAIHA

Showing 1–24 of 686 trials